Payer+Provider's Health System Review
A surgeon mistakes a kidney for a tumor. How can this happen?
Politicians’ Narrow Focus On Prescription Drug Spending Is Myopic
December 3, 2018
“We think that the fit is very strong between Takeda and Shire. We foresee minimal disruption on the R&D front.”
Read the full post on Forbes - Healthcare